The study was observational, and cannot prove cause and effect
Eli Lilly is expected to have its new obesity asset on the market with the triple-agonist retatrutide, reinforcing the shift towards portfolio led strategies that address different stages of treatment and patient needs rather than relying on a single flagship product
[1] It's important to distinguish between the licensed indication and NHS access criteria
Continuous treatment with L-carnitine can help prevent episodes of dangerously low blood sugar (hypoglycemia) and improve symptoms related to muscle weakness
The Association said it has received at least 43 vision-related claims involving Wegovy and other GLP-1 drugs, and many of those are still under review
The conclusion shows that dogs fed with high-calorie diets can benefit from this amino acid because there is a decrease in food intake, and an increase in the basal metabolic rate, which prevents weight gain